Introducing sense into nonsense in treatments of human genetic diseases
- 20 October 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Genetics
- Vol. 24 (11), 552-563
- https://doi.org/10.1016/j.tig.2008.08.010
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR -G542X nonsense allele in a CF mouse modelProceedings of the National Academy of Sciences, 2008
- A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticinProceedings of the National Academy of Sciences of the United States of America, 2007
- Nonsense Mutations in hERG Cause a Decrease in Mutant mRNA Transcripts by Nonsense-Mediated mRNA Decay in Human Long-QT SyndromeCirculation, 2007
- The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathwayNucleic Acids Research, 2007
- An alternative branch of the nonsense-mediated decay pathwayThe EMBO Journal, 2007
- The highways and byways of mRNA decayNature Reviews Molecular Cell Biology, 2007
- hUPF2 Silencing Identifies Physiologic Substrates of Mammalian Nonsense-Mediated mRNA DecayMolecular and Cellular Biology, 2006
- Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutationsNature Genetics, 2004
- Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humansProceedings of the National Academy of Sciences, 2002
- A strategy for disease gene identification through nonsense-mediated mRNA decay inhibitionNature Biotechnology, 2001